A detailed history of Birchview Capital, LP transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 1,655,184 shares of AZYO stock, worth $2.4 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
1,655,184
Previous 1,655,184 -0.0%
Holding current value
$2.4 Million
Previous $2.37 Million 1.44%
% of portfolio
2.06%
Previous 2.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$1.19 - $4.96 $166,600 - $694,400
140,000 Added 9.24%
1,655,184 $2.5 Million
Q4 2022

Feb 03, 2023

BUY
$3.48 - $8.94 $337,772 - $867,725
97,061 Added 6.84%
1,515,184 $6.44 Million
Q2 2022

Aug 12, 2022

BUY
$5.75 - $7.41 $1,150 - $1,482
200 Added 0.01%
1,418,123 $10 Million
Q4 2021

Feb 14, 2022

BUY
$4.1 - $6.82 $5.61 Million - $9.33 Million
1,367,923 Added 2735.85%
1,417,923 $8.35 Million
Q3 2021

Nov 12, 2021

BUY
$6.75 - $9.52 $135,000 - $190,400
20,000 Added 66.67%
50,000 $348,000
Q2 2021

Aug 10, 2021

BUY
$9.51 - $13.97 $285,300 - $419,100
30,000 New
30,000 $288,000

Others Institutions Holding AZYO

About AZIYO BIOLOGICS, INC.


  • Ticker AZYO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,308,720
  • Market Cap $13.5M
  • Description
  • Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...
More about AZYO
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.